Muthoot MCred Q1 FY27 reports 232.73% PAT growth to ₹100.29 crore, while AUM rises 58.53% to ₹7,098.38 crore.
Read MorePAT growth
Emcure Pharmaceuticals Q1 FY27: Revenue Rises 23% to ₹25,804 Million, PAT Jumps 36%
Emcure Pharmaceuticals Q1 FY27 reports 22.8% revenue growth to ₹25,804 million, while PAT jumps 36.2% and EBITDA rises 25.8% in Q1 FY27.
Read More
ASMS FY26 Revenue Surpasses ₹100 Crore; PAT Jumps Over 240%, Net Worth Turns Positive
ASMS FY26 reports ₹103.96 crore revenue, 160% growth, PAT up over 240%, positive net worth, and strong expansion across agritech and healthcare.
Read More
Justo RealFintech FY26: Revenue Rises 13.7% to ₹93 Crore, PAT Grows 30.5%
Justo RealFintech FY26 reports ₹93 crore revenue, 30.5% PAT growth, 34.9% EBITDA rise and a ₹9,000 crore mandate pipeline for future expansion.
Read More
Tata Elxsi Q4 FY26: Revenue at ₹993.8 Cr, PBT Margin Surges 10.7% QoQ
Tata Elxsi Q4 FY26 reports ₹993.8 Cr revenue, strong margin growth, strategic deals, and ₹75 dividend announcement.
Read More